MBTPS2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.607600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.890790E-01
Normal-vs-Stage2
4.644000E-01
Normal-vs-Stage3
4.533800E-01
Normal-vs-Stage4
4.401200E-01
Stage1-vs-Stage2
2.694200E-01
Stage1-vs-Stage3
3.232000E-02
Stage1-vs-Stage4
8.791600E-01
Stage2-vs-Stage3
1.233770E-01
Stage2-vs-Stage4
4.997600E-01
Stage3-vs-Stage4
1.770810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.807400E-01
Normal-vs-AfricanAmerican
1.494990E-01
Normal-vs-Asian
7.590600E-01
Caucasian-vs-AfricanAmerican
4.220200E-01
Caucasian-vs-Asian
4.032600E-01
AfricanAmerican-vs-Asian
1.301630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.008600E-01
Normal-vs-Female
4.176400E-01
Male-vs-Female
3.106200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.129400E-01
Normal-vs-Age(41-60Yrs)
2.468000E-01
Normal-vs-Age(61-80Yrs)
6.138800E-01
Normal-vs-Age(81-100Yrs)
7.784200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.056000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.131000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.735210E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.955980E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.216100E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.711200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.277400E-01
Normal-vs-Daily Drinker
6.764600E-01
Normal-vs-Weekly Drinker
5.257600E-01
Normal-vs-Occasional Drinker
2.350400E-01
Normal-vs-Social Drinker
5.335400E-01
Non Drinker-vs-Daily Drinker
9.306000E-01
Non Drinker-vs-Weekly Drinker
6.160800E-01
Non Drinker-vs-Occasional Drinker
3.999600E-02
Non Drinker-vs-Social Drinker
3.067800E-01
Daily Drinker-vs-Weekly Drinker
6.649400E-01
Daily Drinker-vs-Occasional Drinker
5.503600E-02
Daily Drinker-vs-Social Drinker
3.256200E-01
Weekly Drinker-vs-Occasional Drinker
1.848990E-01
Weekly Drinker-vs-Social Drinker
4.526200E-01
Occasional Drinker-vs-Social Drinker
9.444800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.910000E-01
Normal-vs-Grade 2
2.786200E-01
Normal-vs-Grade 3
2.484000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.819200E-01
Grade 1-vs-Grade 3
8.781600E-01
Grade 1-vs-Grade 4
4.910000E-01
Grade 2-vs-Grade 3
1.704450E-01
Grade 2-vs-Grade 4
2.786200E-01
Grade 3-vs-Grade 4
2.484000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.083800E-01
Normal-vs-NonDiabetic
4.637600E-01
Diabetic-vs-NonDiabetic
5.910000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.385800E-01
Normal-vs-NoPancreatitis
4.809000E-01
Pancreatitis-vs-NoPancreatitis
4.372500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.051200E-01
Normal-vs-N1
4.544400E-01
N0-vs-N1
5.523200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.614400E-01
Normal-vs-TP53-NonMutant
4.501800E-01
TP53-Mutant-vs-TP53-NonMutant
4.838600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
